Abstract:Chemodynamic therapy (CDT) is an emerging cancer treatment strategy that uses CDT agents to convert hydrogen peroxide (H2O2) into the hydroxyl radical (OH), the most harmful reactive oxygen species (ROS) by the Fenton/Fenton-like reactions, thus inducing cell apoptosis and necrosis. This treatment method has been widely studied because of its minimal invasiveness and high tumor specificity, and has become a popular topic of research. Despite the great potential of CDT in tumor treatment, the clinical conversion of CDT is still facing challenges: 1) the relatively high pH of the tumor sites is not suitable for the occurrence of most Fenton/Fenton-like reactions; 2) the low concentration of endogenous H2O2 at the tumors is not enough to generate continuous ROS such as OH; and 3) the high expression of reducing substances (e.g., glutathione, GSH) in the tumor microenvironment (TME) weakens the therapeutic effect of CDT. These limitations make it difficult for CDT alone to completely eliminate malignant tumors. Therefore, CDT-based combined treatment strategies have been widely developed. CDT-based combined therapy refers to the combination of CDT and other cancer treatments (e.g., photo-induced therapy, chemotherapy, sonodynamic therapy, starvation therapy, and gas therapy), which can produce a synergistic anticancer effect. This combined therapy can reduce individual drug-related toxicity and significantly enhance therapeutic efficiency, which has recently seen rapid development. This review begins by defining CDT, then it identifies the problems faced in CDT and proposes various strategies to enhance CDT performance, primarily focusing on CDT-based combined cancer treatment. The problems, opportunities, and challenges of CDT-based combination cancer therapy are also summarized, thereby providing a reference for the future development of CDT-based combined therapy.

Enhanced Transcutaneous Chemodynamic Therapy for Melanoma Treatment through Cascaded Fenton-like Reactions and Nitric Oxide Delivery

Current Progress in the Regulation of Endogenous Molecules for Enhanced Chemodynamic Therapy.

Recent advances in enhanced chemodynamic therapy strategies

Current Progress on the Regulation of Endogenous Molecules for Enhanced Chemodynamic Therapy

A Spark to the Powder Keg: Microneedle-based Antitumor Nanomedicine Targeting Reactive Oxygen Species Accumulation for Chemodynamic/photothermal/chemotherapy

Boosting H2O2‐Guided Chemodynamic Therapy of Cancer by Enhancing Reaction Kinetics Through Versatile Biomimetic Fenton Nanocatalysts and the Second Near‐Infrared Light Irradiation

Mesoporous Silicon Based Nano-Particles for Photothermal and H2O2-elevation Dually-Augmented Chemodynamic Therapy

Self-Supply Oxygen ROS Reactor via Fenton-like Reaction and Modulating Glutathione for Amplified Cancer Therapy Effect

A Combination of Biocatalysis and Fenton-Like Reaction Induced OH• Burst for Cascade Amplification of Cancer Chemodynamic Therapy

In-Situ-Bloomed Micrometer-Scale Ultrathin Nanosheets in Tumor-Microenvironment for Intensive Photothermal-Enhanced Chemodynamic Therapy

Self-assembled Nanoplatforms for Chemodynamic Therapy

Sequential Catalytic, Magnetic Targeting Nanoplatform for Synergistic Photothermal and NIR-Enhanced Chemodynamic Therapy

Fenton-like nanoparticles capable of H2O2 self-supply and glutathione consumption for chemodynamic and chemotherapy of cancer

Boosting Chemodynamic Therapy via a Synergy of Hypothermal Ablation and Oxidation Resistance Reduction

Chemodynamic Therapy: Integration of Fenton Chemistry and Biomedicine

Mild Hyperthermia-Enhanced Enzyme-Mediated Tumor Cell Chemodynamic Therapy.

Recent progress of chemodynamic therapy-induced combination cancer therapy

Progress and Applications of Chemodynamic Therapy in Cancer Therapy

Hydrogen peroxide self-sufficient and glutathione-depleted nanoplatform for boosting chemodynamic therapy synergetic phototherapy

Cu-MOF chemodynamic nanoplatform via modulating glutathione and H2O2 in tumor microenvironment for amplified cancer therapy

Recent advances in enhancing reactive oxygen species based chemodynamic therapy